We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Click here to add this to my saved trials
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Updated: 1/4/2017
A Phase 2a Open-Label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 1/4/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Multi-Center Study of the Safety and Efficacy of Topically Applied MEBO Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Venous Leg Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Venous Leg Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Venous Leg Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Venous Leg Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
Updated: 1/10/2017
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers
Status: Enrolling
Updated: 1/10/2017
Click here to add this to my saved trials
Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation
Updated: 1/11/2017
Sirolimus Switching From Calcinurin Inhibitors (CNI) 90 - 180 Days After Liver Transplantation
Status: Enrolling
Updated: 1/11/2017
Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation
Updated: 1/11/2017
Sirolimus Switching From Calcinurin Inhibitors (CNI) 90 - 180 Days After Liver Transplantation
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers
Updated: 1/11/2017
Phase 1, Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers
Status: Enrolling
Updated: 1/11/2017
Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers
Updated: 1/11/2017
Phase 1, Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Lofexidine for Opiate Withdrawal - 1
Updated: 1/11/2017
A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal
Status: Enrolling
Updated: 1/11/2017
Lofexidine for Opiate Withdrawal - 1
Updated: 1/11/2017
A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Lofexidine for Opiate Withdrawal - 1
Updated: 1/11/2017
A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal
Status: Enrolling
Updated: 1/11/2017
Lofexidine for Opiate Withdrawal - 1
Updated: 1/11/2017
A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Lofexidine for Opiate Withdrawal - 1
Updated: 1/11/2017
A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal
Status: Enrolling
Updated: 1/11/2017
Lofexidine for Opiate Withdrawal - 1
Updated: 1/11/2017
A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
Updated: 1/11/2017
The Acute and Protracted Blockade Efficacy of Buprenorphine/Naloxone
Status: Enrolling
Updated: 1/11/2017
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
Updated: 1/11/2017
The Acute and Protracted Blockade Efficacy of Buprenorphine/Naloxone
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
Updated: 1/11/2017
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals
Status: Enrolling
Updated: 1/11/2017
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
Updated: 1/11/2017
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Addition of Naltrexone to Methadone Taper
Updated: 1/11/2017
Place of Low-Dose Naltrexone in Opiate Detoxification
Status: Enrolling
Updated: 1/11/2017
Addition of Naltrexone to Methadone Taper
Updated: 1/11/2017
Place of Low-Dose Naltrexone in Opiate Detoxification
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals
Updated: 1/11/2017
Biobehavioral Studies of Opioid Drug Seeking Behavior: Study 1
Status: Enrolling
Updated: 1/11/2017
Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals
Updated: 1/11/2017
Biobehavioral Studies of Opioid Drug Seeking Behavior: Study 1
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia
Updated: 1/11/2017
Hyperalgesia in Methadone Patients: Can it be Treated?
Status: Enrolling
Updated: 1/11/2017
Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia
Updated: 1/11/2017
Hyperalgesia in Methadone Patients: Can it be Treated?
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
Updated: 1/11/2017
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients
Status: Enrolling
Updated: 1/11/2017
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
Updated: 1/11/2017
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
Updated: 1/11/2017
Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal
Status: Enrolling
Updated: 1/11/2017
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
Updated: 1/11/2017
Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
Updated: 1/11/2017
Effects of Buprenophine and Naloxone in Opiate Addicts
Status: Enrolling
Updated: 1/11/2017
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
Updated: 1/11/2017
Effects of Buprenophine and Naloxone in Opiate Addicts
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
Updated: 1/11/2017
Pharmacokinetics of LAAM in Methadone Patients
Status: Enrolling
Updated: 1/11/2017
Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
Updated: 1/11/2017
Pharmacokinetics of LAAM in Methadone Patients
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Buprenorphine Maintenance for Opiate Dependence - 6
Updated: 1/11/2017
Buprenorphine Maintenance for Opiate Dependence
Status: Enrolling
Updated: 1/11/2017
Buprenorphine Maintenance for Opiate Dependence - 6
Updated: 1/11/2017
Buprenorphine Maintenance for Opiate Dependence
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2
Updated: 1/11/2017
PK 0396 - Buprenorphine Dose Escalation Trial
Status: Enrolling
Updated: 1/11/2017
Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2
Updated: 1/11/2017
PK 0396 - Buprenorphine Dose Escalation Trial
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
Updated: 1/11/2017
Transitioning Patients From Methadone to Buprenorphine/Naloxone for Treating Opioid Dependence
Status: Enrolling
Updated: 1/11/2017
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
Updated: 1/11/2017
Transitioning Patients From Methadone to Buprenorphine/Naloxone for Treating Opioid Dependence
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
Updated: 1/11/2017
Dextroamphetamine as an Adjunct in Cocaine/Opiate Dependent Patients
Status: Enrolling
Updated: 1/11/2017
Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
Updated: 1/11/2017
Dextroamphetamine as an Adjunct in Cocaine/Opiate Dependent Patients
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
Updated: 1/11/2017
Buprenorphine Maintenance Dose Schedule and Treatment Setting: Pilot
Status: Enrolling
Updated: 1/11/2017
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
Updated: 1/11/2017
Buprenorphine Maintenance Dose Schedule and Treatment Setting: Pilot
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
Updated: 1/11/2017
Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution
Status: Enrolling
Updated: 1/11/2017
Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
Updated: 1/11/2017
Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Evaluation of Liquid vs. Tablet Buprenorphine - 6
Updated: 1/11/2017
Pharmacokinetics and Bioavailability of Liquid vs Tablet Buprenorphine
Status: Enrolling
Updated: 1/11/2017
Evaluation of Liquid vs. Tablet Buprenorphine - 6
Updated: 1/11/2017
Pharmacokinetics and Bioavailability of Liquid vs Tablet Buprenorphine
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
Updated: 1/11/2017
Trial of Buprenorphine/Naloxone for Treatment of Opiate Dependence
Status: Enrolling
Updated: 1/11/2017
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
Updated: 1/11/2017
Trial of Buprenorphine/Naloxone for Treatment of Opiate Dependence
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10
Updated: 1/11/2017
Evaluation of Lofexidine for Treatment of Opiate Withdrawal
Status: Enrolling
Updated: 1/11/2017
Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10
Updated: 1/11/2017
Evaluation of Lofexidine for Treatment of Opiate Withdrawal
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
Updated: 1/11/2017
Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal
Status: Enrolling
Updated: 1/11/2017
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
Updated: 1/11/2017
Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
Updated: 1/11/2017
CS1008A Efficacy/Safety Trial of Buprenorphine/Naloxone
Status: Enrolling
Updated: 1/11/2017
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
Updated: 1/11/2017
CS1008A Efficacy/Safety Trial of Buprenorphine/Naloxone
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
Updated: 1/11/2017
CS1008 A&B Eff/Safety Trial of BUP/NX for the Treatment of Opiate Dependence
Status: Enrolling
Updated: 1/11/2017
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
Updated: 1/11/2017
CS1008 A&B Eff/Safety Trial of BUP/NX for the Treatment of Opiate Dependence
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Buprenorphine and Naloxone Combination Study - 10
Updated: 1/11/2017
PK0496 Pharmacokinetics of Buprenorphine
Status: Enrolling
Updated: 1/11/2017
Buprenorphine and Naloxone Combination Study - 10
Updated: 1/11/2017
PK0496 Pharmacokinetics of Buprenorphine
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
Updated: 1/11/2017
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules
Status: Enrolling
Updated: 1/11/2017
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
Updated: 1/11/2017
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
Updated: 1/11/2017
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules
Status: Enrolling
Updated: 1/11/2017
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
Updated: 1/11/2017
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials